I. Travaux,

O. Fain, D. Gobert, C. A. Khau, A. Mekinian, and N. Javaud, Acquired angioedema, Presse Med, vol.27, pp.414-418, 2015.

B. Floccard, N. Javaud, J. Crozon, and T. Rimmelé, Emergency management of bradykinin-mediated angioedema, Presse Med, vol.44, pp.70-77, 2015.

N. Javaud, A. Karami, J. Stirnemann, P. Pilot, A. Branellec et al., Bradykinin-mediated angioedema: factors prompting ED visits, Am J Emerg Med, vol.31, pp.124-133, 2013.

O. Fain, A. Mekinian, D. Gobert, and C. A. Khau, , vol.44, pp.43-50, 2015.

N. Javaud, F. Lapostolle, D. Sapir, M. Dubrel, F. Adnet et al., The early treatment of bradykinin angioedema, a challenge for emergency medicine, Eur J Emerg Med. 2013, vol.20, pp.291-293

A. Nosbaum, L. Bouillet, B. Floccard, N. Javaud, D. Launay et al., Groupe d'experts du CRéAk. Management of angiotensin-converting enzyme inhibitor-related angioedema : recommendations from the French national centre for angioedema, Rev Med Interne, 2013.

A. Branellec, L. Bouillet, N. Javaud, A. Mekinian, I. Boccon-gibod et al.,

. Acquired-c1-inhibitor, Deficiency : 7 patients Treated with Rituximab, J Clin Immunol, vol.32, pp.936-977, 2012.

N. Javaud, O. Fain, B. Bernot, F. Adnet, and F. Lapostolle, Bradykinin-mediated angioedema secondary to angiotensin converting enzyme : initiate treatment from the prehospital phase, Ann Fr Anesth Reanim, vol.30, pp.848-50, 2011.

O. Fain, A. Branellec, M. Dubrel, and N. Javaud, Hereditary angioedema, Rev Prat, vol.61, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02318184

N. Javaud, D. Cantin, N. Smaiti, F. Carpentier, L. Bouillet et al., Facteurs associés à une hospitalisation lors des crises aigues d'angioedème héréditaire : une étude prospective multicentrique, 2015.

J. Achamlal, M. Youssef, F. Lapostolle, A. Lekouara, L. Hamza et al.,

, Angioedème secondaire aux inhibiteurs de l'enzyme de conversion : prise en charge en urgence et critères dhospitalisation, 2015.

N. Javaud, B. Floccard, F. Gontier, F. Lapostolle, I. Boccon-gibod et al., Angioedèmes bradykiniques : facteurs associés à une admission en réanimation, une étude multicentrique, 2015.

N. Javaud, B. Floccard, F. Gontier, I. Boccon-gibod, L. Martin et al., Angioedèmes bradykiniques : facteurs associés à une hospitalisation en réanimation. 68 ème Congrès de la SNFMI, 2013.

S. Javaud, F. Charpentier, D. Lapostolle, M. Lekouara, G. Boubaya et al., Sévérité des angioedèmes bradykiniques médicamenteux : étude comparative avec les formes héréditaires, 2013.

S. Javaud, F. Charpentier, D. Lapostolle, M. Lekouara, G. Boubaya et al., Sévérité des angioedèmes bradykiniques médicamenteux : étude comparative avec les formes héréditaires. 66 ème Congrès de la Société Nationale Française de Médecine Interne, pp.12-14, 2012.

F. Javaud, D. Carpentier, N. Cantin, D. Smaiti, F. Launay et al., Angioedème héréditaire aux urgences, 2012.

P. G. Reuter, C. Rouchy, S. Cattan, H. Benamer, T. Jullien et al., Early invasive strategy in high-risk acute coronary syndrome without ST-segment elevation. The SISCA randomized trial, Int J Cardiol, vol.27, pp.414-418, 2014.

Y. Freund, P. Jabre, J. Mourad, F. Lapostolle, P. G. Reuter et al., Relative adrenal insufficiency in critically ill patient after rapid sequence intubation : KETASED ancillary study, J Crit Care, 2014.

P. Morel, S. Melboucy-belkhir, A. Mekinian, N. Javaud, and O. Fain, Herpes simplex encephalitis. Rev Prat, vol.63, p.1196, 2013.

J. Gras, A. Mekinian, N. Javaud, L. Boukari, and O. Fain, Tongue necrosis in giant cell arteritis, Rev Prat, vol.63, p.602, 2013.

D. Pateron, E. Vicaut, E. Debuc, K. Sahraoui, N. Carbonell et al., for the HDUPE Collaborative Study Group. Erythromycin Infusion or Gastric Lavage for Upper Gastrointestinal Bleeding: A Multicenter Randomized Controlled Trial, Ann Emerg Med, vol.57, pp.582-591, 2011.

N. Javaud, D. Silva-certal, R. Stirnemann, J. Morin, A. S. Chamouard et al., Tuberculous cerebral vasculitis : retrospective study of 10 cases, Eur J Intern Med Epub, pp.99-104, 2011.

N. Javaud, X. Belenfant, J. Stirnemann, J. Laederich, M. Ziol et al., Renal Granulomatoses : A Retrospective Study of 40 Cases and Review of the Literature, Medicine (Baltimore), vol.86, pp.170-80, 2007.

, Communications orales et posters

C. Rouchy, P. G. Reuter, S. Cattan, H. Benamer, A. Beruben et al., Une stratégie invasive débutée en préhospitalier améliore l'évolution du syndrome coronarien aigu sans élévation du segment ST. Etude SISCA, 2014.

M. Desmaizieres, J. Franchitti, P. G. Reuter, M. Galinski, M. Woimant et al., Connaissance de leurs traitements par les Patients. Etude COPA, 2014.

H. Akodad, N. Javaud, T. Petrovic, P. G. Reuter, P. Orer et al., Diagnostic of electrocardiograms ECG abnormalities of by residents. VII th Mediterranean Emergency Medicine Congress. 8-11 Septembre, p.150, 2013.

F. Lapostolle, D. Lapostolle, K. Lapostolle, A. Sayah, H. Akodad et al., ECG quality in emergency medicine. Subjective and objective analysis. VIIth Mediterranean Emergency Medicine Congress. 8-11 Septembre, p.171, 2013.

P. Mahadevan, T. Petrovic, H. Akodad, P. G. Reuter, N. Javaud et al., ECG in emergency medicine. The electrodes on the breast or under the breast ? VIIth Mediterranean Emergency Medicine Congress. 8-11 Septembre, p.168, 2013.

F. Adnet, . Debuc, . Gardy, C. Javaud, . Lejeune et al., Hémorragies digestives aiguës hautes du sujet âgé vues aux urgences : caractéristiques et pronostic. Urgences, 2013.

M. Woimant, . Orer, M. Dufau, . Desmaizières, . Agostinucci et al., Impact de l'utilisation d'électrodes précablées sur la nécessité de "refaire" un ECG, 2013.

M. Desmaizières, N. Kessler, M. Javaud, . Woimant, R. Petrovic et al., Evaluation du temps total gagné par l'utilisation d'électrodes à ECG précablées, 2013.

A. Akodad, . Ha-chauvat, P. Gasmi, M. Orer, . Woimant et al., Diagnostic des principales anomalies ECG par les internes en formation, 2013.

A. Sayah, N. Javaud, P. Orer, F. P. Auffredou, A. Yap et al., Qualités des ECG analysés aux urgences. Analyse subjective et objective, 2013.

P. Bertrand, . Agostinucci, M. Petrovic, P. Woimant, . Orer et al.,

, Délai de mise en action de l'Auto-CPR®, nouveau dispositif automatisé de massage cardiaque externe, 2013.

B. Dahan, P. Petrovic, . Pes, . Adnet, . Javaud et al., Mesure du diamètre pupillaire par échographie. The PUPUS Study, vol.152, 2012.

P. Bertrand, . Agostinucci, . Fp-auffredou, . Devallière, G. Javaud et al., Impact de l'utilisation d'un nouveau dispositif de massage cardiaque externe (Auto-CPR) sur les conditions d'intubation : Etude Intub-Air-CP, vol.369, 2012.

N. Javaud, G. Galinski, . Lenoir, . Petrovic, P. Alheritiaire et al., Etude REAV-Repérage Echographique pour Abord Veineux

R. Certal, N. Javaud, . Stirnemann, . Fantin, . Bouchaud et al., Vascularites cérébrales tuberculeuses : 10 observations. 60 ème Congrès de la Société Nationale Française de Médecine Interne, 2009.

N. Picard, . Boursier, C. Javaud, . Birlouez, . Nekhili et al., Réalité de la médicalisation préhospitalière ; durée de médicalisation ; Score de geste, 2007.

N. Picard, M. Boursier, . Youssef, . Javaud, . Cerceau et al., Décision de réanimer en cas d'état de mort apparente : effet du médecin, 2007.

N. Javaud, . Belenfant, P. Laederich, . Ronco, P. Stirnemann et al.,

, Granulomatoses rénales : 40 observations dans, 2006.

. Jl-sebbah, . Martin, . Javaud, . Roudiak, . Boursier et al., Qualité de la sédation en SMUR évaluée par l'index bispectral. 48 ème Congrès National d'Anesthésie et de Réanimation

N. Javaud, . Ziol, . Stirnemann, P. Laederich, P. Callard et al., Granulomatoses rénales : 40 observations dans le Nord-Est parisien

N. Javaud, . Letellier, . Stirnemann, H. Chamouard, S. Nunes et al., Vascularites cérébrales tuberculeuses : 4 observations. 50 ème Congrès de la Société Nationale Française de Médecine Interne III, PROJETS EN COURS

, Etude multicentrique prospective randomisée COURAGE « corticothérapie dans l'urticaire aigue », PHRC National, vol.9, 2015.

A. Banerji, S. Clark, M. Blanda, F. Lovecchio, B. Snyder et al., Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department, Ann Allergy Asthma Immunol, vol.100, issue.4, pp.327-359, 2008.

K. Bork, J. Hardt, K. H. Schicketanz, and N. Ressel, Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency, Arch Intern Med, vol.163, issue.10, pp.1229-1264, 2003.

V. Fremeaux-bacchi, M. T. Guinnepain, P. Cacoub, M. A. Dragon-durey, L. Mouthon et al., Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2, Am J Med, vol.113, issue.3, pp.194-203, 2002.

M. Cicardi, W. Aberer, A. Banerji, M. Bas, J. A. Bernstein et al., Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group, Allergy, vol.69, issue.5, pp.602-618, 2014.

K. Bork, K. Siedlecki, S. Bosch, R. E. Schopf, and W. Kreuz, Asphyxiation by laryngeal edema in patients with hereditary angioedema, Mayo Clin Proc, vol.75, issue.4, pp.349-54, 2000.

K. Bork, P. Staubach, A. J. Eckardt, and J. Hardt, Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency, Am J Gastroenterol, vol.101, issue.3, pp.619-646, 2006.

C. Guichon, B. Floccard, B. Coppere, E. Hautin, F. Bages-limoges et al., One hypovolaemic shock...two kinin pathway abnormalities, Intensive Care Med, vol.37, issue.7, pp.1227-1235, 2011.

B. L. Zuraw, Clinical practice. Hereditary angioedema, N Engl J Med, vol.359, issue.10, pp.1027-1063, 2008.

M. Cicardi, K. Bork, T. Caballero, T. Craig, H. H. Li et al., Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group, Allergy, vol.67, issue.2, pp.147-57, 2012.

H. Longhurst and M. Cicardi, Hereditary angio-oedema, Lancet, vol.379, issue.9814, pp.474-81, 2012.

K. Bork, J. Hardt, and G. Witzke, Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency, J Allergy Clin Immunol, 2012.

T. J. Craig, A. K. Bewtra, S. L. Bahna, D. Hurewitz, L. C. Schneider et al., C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study, Allergy, vol.66, issue.12, pp.1604-1615, 2011.

T. Bowen, M. Cicardi, H. Farkas, K. Bork, H. J. Longhurst et al., International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema, Allergy Asthma Clin Immunol, vol.6, issue.1, p.24, 2010.

M. Cicardi, L. C. Zingale, L. Bergamaschini, and A. Agostoni, Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment, Arch Intern Med, vol.164, issue.8, pp.910-913, 2004.

J. B. Kostis, H. J. Kim, J. Rusnak, T. Casale, A. Kaplan et al., Incidence and characteristics of angioedema associated with enalapril, Arch Intern Med, vol.165, issue.14, pp.1637-1679, 2005.

D. R. Miller, S. A. Oliveria, D. R. Berlowitz, B. G. Fincke, P. Stang et al., Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors, Hypertension, vol.51, issue.6, pp.1624-1654, 2008.

M. A. Pfeffer, J. J. Mcmurray, E. J. Velazquez, J. L. Rouleau, L. Kober et al., Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both, N Engl J Med, vol.349, issue.20, pp.1893-906, 2003.

B. R. Haymore, J. Yoon, C. P. Mikita, M. M. Klote, and K. J. Dezee, Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis, Ann Allergy Asthma Immunol, vol.101, issue.5, pp.495-504, 2008.

J. Blacher, J. Halimi, O. Hanon, J. Mourad, A. Pathak et al., Management of hypertension in adults: the 2013 French Society of Hypertension guidelines, Fundam Clin Pharmacol, vol.28, issue.1, pp.1-9, 2014.

C. Marant, I. Romon, S. Fosse, A. Weill, D. Simon et al., French medical practice in type 2 diabetes: the need for better control of cardiovascular risk factors, Diabetes Metab, vol.34, issue.1, pp.38-45, 2008.

H. Tunstall-pedoe, K. Kuulasmaa, P. Amouyel, D. Arveiler, A. M. Rajakangas et al., Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents, Circulation, vol.90, issue.1, pp.583-612, 1994.

H. M. Bluestein, T. A. Hoover, A. S. Banerji, C. A. Camargo, A. Reshef et al., Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department, Ann Allergy Asthma Immunol, vol.103, issue.6, pp.502-509, 2009.

N. J. Brown, S. Byiers, D. Carr, M. Maldonado, and B. A. Warner, Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema, Hypertension, vol.54, issue.3, pp.516-539, 2009.

M. Duerr, P. Glander, F. Diekmann, D. Dragun, H. H. Neumayer et al., Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients, Clin J Am Soc Nephrol, vol.5, issue.4, pp.703-711, 2010.

M. Bova, M. Guilarte, A. Sala-cunill, P. Borrelli, G. Rizzelli et al., Treatment of ACEI-related angioedema with icatibant: a case series, Intern Emerg Med, 2015.

M. Ba?, J. Greve, K. Stelter, M. Havel, U. Strassen et al., A randomized trial of icatibant in ACE-inhibitor-induced angioedema, N Engl J Med, vol.372, issue.5, pp.418-443, 2015.

J. R. Roberts, J. J. Lee, and D. A. Marthers, Angiotensin-Converting Enzyme (ACE) Inhibitor Angioedema: The Silent Epidemic, Am J Cardiol, vol.109, issue.5, pp.774-779, 2012.

D. E. Dean, D. L. Schultz, and R. H. Powers, Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease, J Forensic Sci, vol.46, issue.5, pp.1239-1282, 2001.

D. A. Wilson, K. Bork, E. P. Shea, A. M. Rentz, M. B. Blaustein et al., Economic costs associated with acute attacks and long-term management of hereditary angioedema, Ann Allergy Asthma Immunol, vol.104, issue.4, pp.314-320, 2010.

E. Aygören-pürsün, A. Bygum, K. Beusterien, E. Hautamaki, Z. Sisic et al., Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe, Orphanet J Rare Dis, vol.9, p.99, 2014.

I. Martinez-saguer, E. Rusicke, E. Aygoren-pursun, C. Heller, T. Klingebiel et al., Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate, Am J Obstet Gynecol, vol.203, issue.2, pp.131-132, 2010.

L. Bouillet, A. Lehmann, A. Gompel, I. Boccon-gibod, D. Launay et al.,

P. Fr, , vol.44, pp.526-558, 1983.

B. L. Zuraw, P. J. Busse, M. White, J. Jacobs, W. Lumry et al., Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema, N Engl J Med, vol.363, issue.6, pp.513-535, 2010.

M. Cicardi, A. Banerji, F. Bracho, A. Malbran, B. Rosenkranz et al., Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema, N Engl J Med, vol.363, issue.6, pp.532-573, 2010.

K. Bork, Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor, Allergy Asthma Clin Immunol, vol.6, issue.1, p.15, 2010.

C. Wintenberger, I. Boccon-gibod, D. Launay, O. Fain, G. Kanny et al., Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients, Clin Exp Immunol, vol.178, issue.1, pp.112-119, 2014.

E. W. Nielsen and S. Gramstad, Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate, Acta Anaesthesiol Scand, vol.50, issue.1, pp.120-122, 2006.

E. R. Rasmussen and A. Bygum, ACE-inhibitor induced angio-oedema treated with complement C1-inhibitor concentrate, BMJ Case Rep, 2013.

A. Nosbaum, L. Bouillet, B. Floccard, N. Javaud, D. Launay et al., Management of angiotensin-converting enzyme inhibitor-related angioedema: recommendations from the French National Center for Angioedema, vol.34, pp.209-222, 2013.

N. Javaud, A. Karami, J. Stirnemann, F. Pilot, A. Branellec et al., Bradykinin-mediated angioedema: factors prompting ED visits, Am J Emerg Med, vol.31, issue.1, pp.124-133, 2013.

N. Javaud, F. Lapostolle, D. Sapir, M. Dubrel, F. Adnet et al., The early treatment of bradykinin angioedema, a challenge for emergency medicine, Eur J Emerg Med Off J Eur Soc Emerg Med, vol.20, issue.4, pp.291-293, 2013.

N. Javaud, B. Floccard, F. Gontier, F. Lapostolle, I. Boccon-gibod et al., Bradykinin-mediated angioedema: factors associated with admission to an intensive care unit, a multicenter study, Eur J Emerg Med Off J Eur Soc Emerg Med, 2015.

J. P. Vandenbroucke, E. Von-elm, D. G. Altman, P. C. Gotzsche, C. D. Mulrow et al., Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration, PLoS Med, vol.4, issue.10, p.297, 2007.

V. Vitrat-hincky, A. Gompel, C. Dumestre-perard, I. Boccon-gibod, C. Drouet et al., Type III hereditary angio-oedema: clinical and biological features in a French cohort, Allergy, vol.65, issue.10, pp.1331-1337, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00498798

M. Cicardi, L. C. Zingale, E. Pappalardo, A. Folcioni, and A. Agostoni, Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Med Baltim, vol.82, pp.274-81, 2003.

M. Cicardi, P. Bellis, G. Bertazzoni, M. Cancian, M. Chiesa et al., Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts, Intern Emerg Med, vol.9, issue.1, pp.85-92, 2014.

N. Javaud, O. Fain, B. Bernot, F. Adnet, and F. Lapostolle, Bradykinin-mediated angioedema secondary to angiotensin converting enzyme

, Ann Fr Anesth Reanim, vol.30, issue.11, pp.848-50, 2011.

J. Nussberger, M. Cugno, and M. Cicardi, Bradykinin-mediated angioedema, N Engl J Med, vol.347, issue.8, pp.621-623, 2002.

J. Nussberger, M. Cugno, C. Amstutz, M. Cicardi, A. Pellacani et al., Plasma bradykinin in angio-oedema, Lancet, vol.351, issue.9117, pp.1693-1700, 1998.

N. J. Brown, M. Snowden, and M. R. Griffin, Recurrent angiotensin-converting enzyme inhibitor--associated angioedema, JAMA, vol.278, issue.3, pp.232-235, 1997.

M. Bas, J. Greve, K. Stelter, H. Bier, T. Stark et al., Therapeutic Efficacy of Icatibant in Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Case Series, Ann Emerg Med, vol.56, issue.3, pp.278-82, 2010.

L. Beltrami, A. Zanichelli, L. Zingale, R. Vacchini, S. Carugo et al., Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema, J Hypertens, vol.29, issue.11, pp.2273-2280, 2011.

T. Campbell, B. Peckler, R. D. Hackstadt, and A. Payor, ACE Inhibitor-Induced Angioedema of the Bowel, Case Rep Med, p.690695, 2010.

K. Bork, G. Meng, P. Staubach, and J. Hardt, Hereditary angioedema: new findings concerning symptoms, affected organs, and course, Am J Med, vol.119, issue.3, pp.267-74, 2006.

K. Bork, S. E. Barnstedt, P. Koch, and H. Traupe, Hereditary angioedema with normal C1-inhibitor activity in women, Lancet, vol.356, issue.9225, pp.213-220, 2000.

B. L. Zuraw, J. A. Bernstein, D. M. Lang, T. Craig, D. Dreyfus et al., A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema, J Allergy Clin Immunol, vol.131, issue.6, pp.1491-1494, 2013.

H. J. Longhurst, H. Farkas, T. Craig, E. Aygoren-pursun, C. Bethune et al., HAE international home therapy consensus document, Allergy Asthma Clin Immunol, vol.6, issue.1, p.22, 2010.

L. Bouillet, D. Launay, O. Fain, I. Boccon-gibod, J. Laurent et al., Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients, Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol, vol.111, issue.4, pp.290-294, 2013.

K. Bork and S. E. Barnstedt, Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema, Arch Intern Med, vol.161, issue.5, pp.714-722, 2001.

W. Aberer, M. Maurer, A. Reshef, H. Longhurst, S. Kivity et al., Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema, Allergy, 2013.

H. B. Boysen, L. Bouillet, and E. Aygören-pürsün, Challenges of C1-inhibitor concentrate self-administration, Int Arch Allergy Immunol, vol.161, issue.1, pp.21-26, 2013.

M. Levi, G. Choi, C. Picavet, and C. E. Hack, Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency, J Allergy Clin Immunol, vol.117, issue.4, pp.904-912, 2006.

T. J. Craig, M. A. Rojavin, T. Machnig, H. Keinecke, and J. A. Bernstein, Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks, Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol, vol.111, issue.3, pp.211-216, 2013.

M. Maurer, W. Aberer, L. Bouillet, T. Caballero, V. Fabien et al., Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment, PloS One, vol.8, issue.2, p.53773, 2013.

B. Gelee, P. Michel, R. Haas, and F. Boishardy, Angiotensin-converting enzyme inhibitorrelated angioedema: emergency treatment with complement C1 inhibitor concentrate

, Rev Med Interne, vol.29, issue.6, pp.516-525, 2008.

F. Adnet and F. Lapostolle, International EMS systems: France. Resuscitation, vol.63, pp.7-9, 2004.

E. R. Rasmussen, K. Mey, and A. Bygum, Angiotensin-converting enzyme inhibitor-induced angioedema--a dangerous new epidemic, Acta Derm Venereol, vol.94, issue.3, pp.260-264, 2014.

D. E. Wennberg, A. Marr, L. Lang, S. O'malley, and G. Bennett, A randomized trial of a telephone care-management strategy, N Engl J Med, vol.363, issue.13, pp.1245-55, 2010.

M. Zelen, A new design for randomized clinical trials, N Engl J Med, vol.300, issue.22, pp.1242-1247, 1979.

R. Forestier, H. Desfour, J. M. Tessier, A. Francon, A. M. Foote et al., Spa therapy in the treatment of knee osteoarthritis: a large randomised multicentre trial, Ann Rheum Dis, vol.69, issue.4, pp.660-665, 2010.

A. P. Gadisseur, W. G. Breukink-engbers, F. J. Van-der-meer, A. M. Van-den-besselaar, A. Sturk et al., Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial, Arch Intern Med, vol.163, issue.21, pp.2639-2685, 2003.